Two Repair Peptides, Different Strategies
GHK-Cu (copper peptide) and BPC-157 are both studied for tissue repair and regeneration, but they work through substantially different mechanisms and have different tissue affinities. GHK-Cu is a naturally occurring tripeptide that binds copper and regulates gene expression across hundreds of genes involved in skin, wound, and tissue repair — with a strong cosmetic and dermatological research base. BPC-157 is a synthetic 15-amino acid peptide derived from gastric juice with a broader repair profile spanning gut, musculoskeletal, neurological, and vascular tissue.
All products sold by FenaLife are intended strictly for laboratory and academic research purposes. Not for human consumption, injection, or ingestion. These statements have not been evaluated by the FDA.
Compound Profiles
| Property | GHK-Cu | BPC-157 |
|---|---|---|
| Full Name | Glycine-Histidine-Lysine Copper Complex | Body Protection Compound 157 |
| Structure | Tripeptide + copper ion | 15 amino acids |
| Origin | Endogenous — found in human plasma, saliva, urine | Synthetic — derived from gastric juice protein |
| Primary Mechanism | Copper transport, gene expression regulation (~4,000 genes), collagen synthesis | VEGF upregulation, NO modulation, FAK-paxillin pathway |
| Declines with age? | Yes — plasma GHK drops significantly from ~200ng/ml (20s) to ~80ng/ml (60s) | Not endogenous |
| Administration in research | Topical, subcutaneous, IV | Subcutaneous, intramuscular, oral (animal models) |
Mechanisms
GHK-Cu: Copper-Mediated Gene Regulation
GHK-Cu’s mechanism centres on copper transport and gene expression modulation. The tripeptide has high affinity for copper(II) ions and acts as a copper chaperone, delivering copper to copper-dependent enzymes including lysyl oxidase (essential for collagen cross-linking) and superoxide dismutase (antioxidant defence). Beyond copper transport, GHK-Cu has been shown to modulate the expression of approximately 4,000 human genes — upregulating collagen, elastin, and decorin synthesis while downregulating genes associated with inflammation, oxidative stress, and tumour progression. In wound healing models, it attracts immune cells to the wound site, promotes capillary formation, and stimulates fibroblast proliferation and collagen deposition.
BPC-157: VEGF and NO Modulation
BPC-157 works primarily through VEGF upregulation and nitric oxide (NO) pathway modulation. It stimulates angiogenesis at injury sites, modulates the FAK-paxillin pathway (involved in cell adhesion and tendon cell survival), and exerts gastroprotective effects through prostaglandin and NO-dependent mechanisms. Unlike GHK-Cu, BPC-157 does not act as a metal chaperone — its repair effects are driven by growth factor signalling and vascular biology. It is also one of the few peptides with demonstrated oral bioavailability in animal models, surviving GI degradation.
Research Applications Comparison
| Research Area | GHK-Cu | BPC-157 |
|---|---|---|
| Skin / dermal repair | Extensive — the primary research application | Some data, not primary application |
| Collagen synthesis | Strong — direct stimulation via lysyl oxidase | Indirect — via angiogenesis and growth factors |
| Wound closure | Strong preclinical and some clinical data | Moderate |
| Tendon & ligament repair | Limited | Strong — multiple rodent models |
| Gut / GI healing | Limited | Extensive — NSAID damage, IBD, fistula models |
| Neuroprotection | Some data — reduces neuroinflammation | Strong — TBI, spinal cord, peripheral nerve models |
| Anti-aging / gene regulation | Strong — regulates ~4,000 genes including anti-aging targets | Not studied in this context |
| Hair growth | Documented — stimulates follicle enlargement | Not studied |
| Antioxidant | Strong — SOD activation, copper delivery | Moderate — via NO and anti-inflammatory pathways |
Key Differentiators
- GHK-Cu is the dominant choice for dermal research — skin repair, collagen remodelling, cosmetic peptide research, wound healing, and anti-aging gene expression. It is endogenous and declines with age, making it relevant to age-related skin and tissue decline research.
- BPC-157 is the dominant choice for musculoskeletal, gastrointestinal, and neurological repair research. Its breadth of tissue targets and oral bioavailability make it uniquely versatile among repair peptides.
- For comprehensive tissue repair research covering both dermal/systemic repair and gut/tendon/neural repair, both compounds are relevant and non-overlapping enough to be studied together.
Frequently Asked Questions
Is GHK-Cu the same as copper peptide?
Yes. GHK-Cu is the specific copper peptide most studied in research — the tripeptide glycine-histidine-lysine complexed with copper(II). It is the active form responsible for the biological effects attributed to copper peptides in wound healing and cosmetic research. Other copper-peptide complexes exist but GHK-Cu is the most characterised.
Can GHK-Cu and BPC-157 be studied together?
No negative interactions have been reported in the literature. They work through distinct mechanisms (copper/gene regulation vs VEGF/NO signalling) and target different primary tissues, making complementary use plausible. GHK-Cu is included in the KLOW/GLOW blends alongside BPC-157, and these blends have been third-party verified for compound identity.
Does GHK-Cu actually penetrate skin topically?
In research models, topical GHK-Cu shows biological effects suggesting some degree of dermal penetration. The copper complex is small enough to penetrate the stratum corneum to some extent. Most high-dose research on wound healing and gene regulation uses subcutaneous or systemic administration. Topical formulations are the basis of cosmetic copper peptide products, though research-grade administration typically involves injection.
Why does GHK-Cu decline with age?
GHK-Cu is produced endogenously from collagen degradation — the tripeptide is released as collagen is broken down. As collagen production and turnover decline with age, GHK levels fall. Plasma GHK has been measured at approximately 200ng/ml in young adults, declining to approximately 80ng/ml by the sixth decade. This age-related decline has driven interest in GHK-Cu as a research compound for studying the relationship between copper peptide availability and age-related tissue maintenance.
Which compound has more human research data?
GHK-Cu has more direct human data, particularly in wound healing and dermatological applications — some small clinical trials and cosmetic research exist. BPC-157 human data is primarily case series and observational. Both rely heavily on rodent preclinical studies for mechanistic understanding.
Source GHK-Cu and BPC-157 at FenaLife
FenaLife supplies GHK-Cu and BPC-157 10mg with Janoshik third-party COA. Browse the Cosmetic Research and Recovery & Repair categories. Free shipping on orders over $100.
See also: BPC-157 + TB-500 Stack Reference | BPC-157 vs TB-500 Comparison
All products sold by FenaLife are intended strictly for laboratory and academic research purposes. Not for human consumption, injection, or ingestion. These statements have not been evaluated by the FDA.